Abiopharma

🔍 STATON DANIEL C (Director)

Company: Armour Residential REIT, Inc. (ARR)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 1,900 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,103.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 480 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,583.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 1,900 shares of Phantom Stock (Derivative)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 30,344.00 | transaction_form_type: 4 | Footnotes: F4, F1, F1
• Sold 480 shares of Phantom Stock (Derivative)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 29,864.00 | transaction_form_type: 4 | Footnotes: F4, F3, F3

Footnotes:

• F1: On August 21, 2026, the reporting person elected to convert 1,900 shares of vested phantom stock into 1,900 shares of ARMOUR common stock. The 1,900 shares are part of, and relate to, phantom stock vesting over five-year periods, which was reported on Form 4 reports filed by the reporting person on February 14, 2023 , December 18, 2025 and May 21, 2026.
• F2: Represents shares owned indirectly through DM Staton Family Limited Partnership. The reporting person is a general partner and a limited partner of DM Staton Family Limited Partnership. The reporting person has a pecuniary interest in the shares held by DM Staton Family Limited Partnership.
• F3: On August 21, 2026, the reporting person elected to convert 480 shares of vested phantom stock into 480 shares of ARMOUR common stock. The 480 shares are part of, and relate to, phantom stock vesting over a six-and-a half year periods, which was reported on Form 4 report filed by the reporting person on January 14, 2021.
• F4: Each unit of phantom stock is the economic equivalent of one share of ARMOUR common stock.